Category: Drug Discovery
Global Drug Discovery
-
2024 Global Forecast for Plasma Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Plasma Protein Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... 2028, progressing at a CAGR of 10.02%, over the period 2024-2028. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress ... Read More
-
Global Immunomodulators Databank Market Report
... segment is expected to be the highest contributor to this market, with $78,020.3 Million in 2020, and is anticipated to reach $151,171.1 Million by 2029, registering a CAGR of 7.67%. Oncology and Respiratory segments collectively ... Read More
-
Global Multiple Myeloma Therapeutics Databank Market Report
... 2021 to 2029. Medication segment is expected to be the highest contributor to this market, with $8,265.9 Million in 2020, and is anticipated to reach $14,610.5 Million by 2029, registering a CAGR of 6.57%. Medication ... Read More
-
Global Drug Screening Databank Market Report
... 2031. Drug Screening Service segment is expected to be the highest contributor to this market, with $2,091.3 Million in 2022, and is anticipated to reach $5,840.6 Million by 2031, registering a CAGR of 12.15%. Drug ... Read More
-
Global Food Allergy Diagnostics & Therapeutics Databank Market Report
... CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to be the highest contributor to this market, with $2,241.8 Million in 2022, and is anticipated to reach $3,594.6 Million by 2031, registering ... Read More
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More
-
Global Scleroderma Therapeutics Databank Market Report
... 2031. Immunosuppressors segment is expected to be the highest contributor to this market, with $1,235.9 Million in 2022, and is anticipated to reach $1,832.6 Million by 2031, registering a CAGR of 4.52%. Prostacyclin Analogues segment ... Read More
-
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report
... 3.20% from 2023 to 2031. DST-100 segment is expected to be the highest contributor to this market, with $2,017.3 Million in 2022, and is anticipated to reach $2,548.2 Million by 2031, registering a CAGR of ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030
... in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
... from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Myelodysplastic Syndrome Drugs Databank Market Report
... 2023 to 2031. Immunomodulatory Drugs segment is expected to be the highest contributor to this market, with $982.9 Million in 2022, and is anticipated to reach $2,003.9 Million by 2031, registering a CAGR of 8.28%. ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Global Myeloproliferative Disorders Drugs Databank Market Report
... 2023 to 2031. Ph+ CML segment is expected to be the highest contributor to this market, with $6,196.2 Million in 2022, and is anticipated to reach $7,194.7 Million by 2031, registering a CAGR of 1.71%. ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
... 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be the highest contributor to this market, with $1,304.4 Million in 2020, and is anticipated to reach $3,116.3 Million by 2029, registering a CAGR ... Read More
-
Global Celiac Disease Drug Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Celiac Disease Drug industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Celiac Disease Drug. The report also introduces players ... Read More
-
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
... qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Ebola Virus Infection Market - 2024-2031
... the forecast period 2024-2031. Ebola virus disease formerly known as ebola haemorrhagic fever is a severe often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals such as ... Read More
Research Assistance
